site stats

Bio2 technologies inc

WebBio2 Technologies has developed bone graft substitute products for the fast-growing markets of spine and foot and ankle surgery: Proprietary platform technology offering unique combination of bioactivity and strength at a low cost to manufacture. 3) At 24 weeks, substantial trabecular bone was observed in the Vitrium defects with … Vitrium is produced by sintering bioactive glass fibers into a three-dimensional … Vitrium’s combination of the mechanism of action of bioactive glass, structural … Contact Us. Send us an email and we'll get back to you, asap. Send Message. © … Bio2’s product development activities are initially focused on the $1.5 billion … Bio2 Technologies is a privately held medical device company headquartered … WebDec 5, 2024 · WOBURN, Mass., Dec. 5, 2024 /PRNewswire/ -- Bio2 Technologies, Inc., a privately held orthopedic implant company, announced today that Ted Bird and David Gill have been appointed to the Company's ...

Product Pipeline - Bio2 Technologies, Inc.

WebFounded Date 2009. Operating Status Active. Last Funding Type Venture - Series Unknown. Also Known As Bio2 Technologies. Legal Name Novum Medical, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 7817216301. Novum Medical designs innovative orthopedic implants using novel biomaterials to provide an enhanced … WebBI² Technologies™ - Biometric Intelligence and Identification Technologies - is a worldwide leader in the development and implementation of the innovative and affordable iris, fingerprint and facial … rani jeyaraj https://marchowelldesign.com

Bio2 Technologies Enrolls First Vitrium Patient in Cervical Spine ...

WebNov 13, 2024 · About Bio2 Technologies, Inc.: Bio2 Technologies is a privately held medical device company headquartered in Woburn, Massachusetts. Our team is engaged in the development of advanced bioactive ... WebBI² Technologies™ - Biometric Intelligence and Identification Technologies - is a worldwide leader in the development and implementation of the innovative and affordable iris, fingerprint and facial … WebBio2 Technologies, Inc. is a medical device company applying a proprietary fiber bonding process to create advanced resorbable materials for broad application in the $50B musculoskeletal market. The … dr majid jamali reviews

Bio2 Technologies raises $4.3m for ortho biomaterial

Category:bi2technologies.com – Biometric Intelligence

Tags:Bio2 technologies inc

Bio2 technologies inc

Novum Medical Company Profile: Valuation & Investors PitchBook

WebBoston, MA. Novum (formerly Bio2 Technologies) is commercializing novel medical device products for the orthopedic industry. Board member and … WebAbout Bio2 Technologies, Inc. Bio2 Technologies is a privately held medical device company headquartered in Woburn, Massachusetts. Our team is engaged in the development of advanced orthobiomaterials utilizing a proprietary process capable of producing structures that are both strong and porous. The Company also commercializes …

Bio2 technologies inc

Did you know?

WebDec 19, 2014 · WOBURN, Mass., Dec. 19, 2014 /PRNewswire/ -- Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug ... WebSep 11, 2024 · WOBURN, Mass., Sept. 11, 2024 /PRNewswire/ -- Bio2 Technologies, Inc., a privately held orthopedics company, announced today the closing of its Se...

WebEcoCatalytic Technologies Bio2Electric, LLC 305 West Cummings Park Woburn, MA 01801 Phone: +1-978 610 6932 Fax: +1-978 610 6932

WebNov 13, 2024 · Bio2 Technologies is a privately held medical device company headquartered in Woburn, Massachusetts. Our team is engaged in the development of advanced bioactive orthobiomaterials utilizing a... WebAbout Bio2 Technologies, Inc.: Bio2 Technologies is a privately held medical device company headquartered in Woburn, Massachusetts. Our team is engaged in the development of advanced orthobiomaterials utilizing a proprietary process capable of …

WebSep 9, 2024 · Bio2 Technologies (Woburn, Mass.) has raised about $4.3 million as it continues with a clinical trial of its Vitrium resorbable orthopedic biomaterial for musculoskeletal surgery.

WebScaling antibody evolution. Making rare discoveries routine. [email protected] rani jeyaraj yogaWebDec 19, 2014 · WOBURN, Mass., Dec. 19, 2014 /PRNewswire/ -- Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for its CLM Bioactive Scaffold. CLM is constructed from bioactive glass, a resorbable implantable material with … dr majic tomislavWebSep 11, 2024 · About Bio2 Technologies, Inc.: Bio2 Technologies is a privately held medical device company headquartered in Woburn, Massachusetts. Our team is engaged in the development of advanced... dr majuk santa cruzWebNov 13, 2024 · About Bio2 Technologies, Inc.: Bio2 Technologies is a privately held medical device company headquartered in Woburn , Massachusetts. Our team is engaged in the development of advanced bioactive orthobiomaterials utilizing a proprietary process capable of producing resorbable, three-dimensional structures with controlled, … rani jeyrajWebAug 5, 2024 · WOBURN, Mass., Aug. 5, 2024 /PRNewswire/ -- Bio2 Technologies, Inc., the developer of Vitrium, a unique proprietary structural and resorbable orthobiomaterial, announced the first implantation of an index patient in its randomized, multi-center, non-inferiority IDE Vitrium Cervical Interbody clinical trial. Bio2 received FDA approval to … rani jethmalaniWebBio2’s directors and advisors include veteran industry figures and recognized clinical and scientific thought leaders. Our capital efficient business model seeks to drive IRR through engaging strategic partners across multiple sub-specialty market verticals. rani jhansi road route mapWebHome Platform Technology. Bio2’s patented Cross-Linked Microstructure process bonds bioactive glass fiber into a rigid three-dimensional structure. Bioactive glass was first cleared by the FDA in Jan 1985 and has a history of safe … dr majumdar st luke\\u0027s